Mimedx Announces Favorable Federal Court Ruling In Axiofill® Regulatory Classification Matter
MiMedx Group, Inc. NASDAQ:MDXG
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
3 results loaded, newest first. End of these results.
MiMedx Group, Inc. NASDAQ:MDXG
Court Vacates FDA Determinations That AXIOFILL Is Not Minimally Manipulated and Should Be Classified as a Biological ProductOrder Further Holds That Minimal-Manipulation Analysis Must Consider Tissue Characteristics Relevant to Reconstruction, Repair or Replacement in the RecipientMARIETTA, Ga., Se…
MDXG - MIMEDX Announces Favorable Federal Court Ruling in AXIOFILL® Regulatory Classification Matter